Results 131 to 140 of about 75,705 (253)

Growth hormone deficiency in adults and clinical use of recombinant human growth hormone.

Chinese medical journal, 2001
To review the modern recognition of growth hormone deficiency (GHD) in adults and the beneficial effects of growth hormone (GH) treatment in such cases.Most published original articles about GH and GHD in recent domestic and world wide related literatures were available.More than 65 originally identified articles were reviewed and 29 were selected that
openaire   +1 more source

Weekly pegylated recombinant human growth hormone for prepubertal children with growth hormone deficiency: adherence advantage drives superior short-term efficacy over daily rhGH. [PDF]

Transl Pediatr
Guo H, Zhai Y, Yaheyajiang A, Mohemai Z, Liu L, Zheng L, Tuniyazi K.   +6 more
europepmc   +1 more source

Progress On Sensorineural Hearing Loss: Mechanisms and Therapies

Sensory Neuroscience, EarlyView.
ABSTRACT Hearing loss is the most common disabling disease among humans, which adversely affects human health. Sensorineural hearing loss (SNHL) accounting for approximately 63% of all hearing loss cases. SNHL may be classified into age‐related hearing loss (ARHL), drug‐induced hearing loss (DIHL), noise‐induced hearing loss (NIHL), and sudden ...
Yuan Zhang, Shen Li, Yangfan Zhou, Duopin Li, Junru Ding, Ruifeng Qiao, Yutian Chen, Fanglei Ye, Le Wang, Peipei Li   +9 more
wiley   +1 more source

Efficacy and Safety of PEGylated Recombinant Human Growth Hormone in Children With Growth Hormone Deficiency and Idiopathic Short Stature: A Real-World Cohort Study. [PDF]

Int J Endocrinol
Ge L, Zhao C, Yang Y, Xu L, Sun M, Su Y, Xu F, Huang Q, Tao N.   +8 more
europepmc   +1 more source

Blood Lipid Disorders in Post-Operative Craniopharyngioma Children and Adolescents and the Improvement with Recombinant Human Growth Hormone Replacement. [PDF]

Diabetes Metab Syndr Obes, 2023
Du HZ, Chen K, Zhang LY, Zhang YL, Wu DN, Guo XY, Duan L, Wang LJ, Yang HB, Chen S, Pan H, Zhu HJ.   +11 more
europepmc   +1 more source

Phthalate Metabolite, Mono(2‐Ethyl‐5‐Hydroxyhexyl) Phthalate (MEHHP), Promotes Uterine‐Fibroid–Associated Phenotypes in Myometrial Stem Cell‐Derived 3D Organoids

Environmental Toxicology, EarlyView.
ABSTRACT This study investigates how phthalate exposure contributes to uterine fibroid (UF) development by studying the effects of the Mono‐(2‐ethyl‐5‐hydroxyhexyl) phthalate (MEHHP), a metabolite of Di(2‐ethylhexyl) phthalate, on myometrial stem cells (MMSCs).
Somayeh Vafaei, Mervat M. Omran, Qiwei Yang, Sandra Madueke‐Laveaux, Ami R. Zota, Ayman Al‐Hendy, Mohamed Ali   +6 more
wiley   +1 more source

Adherence to recombinant human growth hormone therapy in children: influencing factors and clinical implications. [PDF]

Front Pediatr
Chang W, Jin H, Zhou Q, Ye K, Dai Y.
europepmc   +1 more source

Effect of Recombinant Human Growth Hormone Treatment in a Patient with Short Stature Associated with the Ring Chromosome 17 Syndrome. [PDF]

Case Rep Pediatr, 2023
Tempone Cardoso Penna G, de Rezende Lelot G, de Rezende Lelot AL, Greghi Hernandez J, Costa Figueiredo C, de Araujo Evangelista NM, Tonetto Fernandes VF, de Paula Colares Neto G.   +7 more
europepmc   +1 more source

Recent progress on the development of hydrogel‐based microneedles for transdermal drug delivery

VIEW, EarlyView.
This study provides a comprehensive and up‐to‐date analysis of recent progress in HMN technology, covering fundamental transdermal delivery mechanisms and design principles, biomaterials used in HMN fabrication, drug loading and release strategies, and emerging therapeutic applications.
Mohammad Muhtasim Ittisaf, Salman Farsi Taharat, Md. Sadek Miah, Hasan Tasnim Salehin, M. Azam Ali, Shoeb Ahmed   +5 more
wiley   +1 more source

Global trends in recombinant human growth hormone for the treatment of idiopathic short stature: a bibliometric analysis. [PDF]

Front Med (Lausanne)
Ouyang R, Gu H, Yuan J, Sun Y, Zhao X.
europepmc   +1 more source